CRVS Competitors & Alternatives
Compare Corvus Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
CRVS
Main Stock$10.53
Tradestie Score
61
Market Cap
$540.97M
Analyst Upside
+214.7%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RLAY
Relay Therapeutics, Inc. Common Stock
|
$18.18
|
$917.23M | - | 53 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$17.07
|
$906.29M | - | 60 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$29.36
|
$903.54M | - | 45 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$80.15
|
$900.91M | - | 59 | Compare |
|
GERN
Geron Corp
|
$1.12
|
$899.60M | - | 46 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$48.73
|
$894.30M | - | 52 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$23.34
|
$887.30M | - | 52 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$4.20
|
$879.90M | 5.3 | 70 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$5.74
|
$871.90M | - | 48 | Compare |
|
DNA
Ginkgo Bioworks Holdings, Inc.
|
$9.99
|
$868.46M | - | 56 | Compare |
More CRVS Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry